Characterization of chronic and acute ESA hyporesponse: a retrospective cohort study of hemodialysis patients

Autor Sibbel, Scott P., Koro, Carol E., Brunelli, Steven M., Cobitz, Alexander R.
Vydáno v BMC Nephrol (2015)

An Exploratory Study of Daprodustat in Erythropoietin-Hyporesponsive Subjects

Autor Cizman, Borut, Sykes, Andy P., Paul, Gitanjali, Zeig, Steven, Cobitz, Alexander R.
Vydáno v Kidney Int Rep (2018)

The drug interaction potential of daprodustat when coadministered with pioglitazone, rosuvastatin, or trimethoprim in healthy subjects

Autor Caltabiano, Stephen, Mahar, Kelly M., Lister, Karyn, Tenero, David, Ravindranath, Ramiya, Cizman, Borut, Cobitz, Alexander R.
Vydáno v Pharmacol Res Perspect (2018)

A randomized, 29-day, dose-ranging, efficacy and safety study of daprodustat, administered three times weekly in patients with anemia on hemodialysis

Autor Bailey, Christine K., Caltabiano, Stephen, Cobitz, Alexander R., Huang, Chun, Mahar, Kelly M., Patel, Vickas V.
Vydáno v BMC Nephrol (2019)

Anemia and mortality in patients with nondialysis-dependent chronic kidney disease

Autor Stirnadel-Farrant, Heide A., Luo, Jiacong, Kler, Lata, Cizman, Borut, Jones, Delyth, Brunelli, Steven M., Cobitz, Alexander R.
Vydáno v BMC Nephrol (2018)

Effect of renal function and dialysis modality on daprodustat and predominant metabolite exposure

Autor Caltabiano, Stephen, Cizman, Borut, Burns, Olivia, Mahar, Kelly M, Johnson, Brendan M, Ramanjineyulu, Bandi, Serbest, Gulyeter, Cobitz, Alexander R
Vydáno v Clin Kidney J (2019)

Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia: A Randomized, Double-Blind, Phase 3 Trial

Autor Akizawa, Tadao, Nangaku, Masaomi, Yonekawa, Taeko, Okuda, Nobuhiko, Kawamatsu, Shinya, Onoue, Tomohiro, Endo, Yukihiro, Hara, Katsutoshi, Cobitz, Alexander R.
Vydáno v Clin J Am Soc Nephrol (2020)

Cardiovascular Event Rates Among Hemodialysis Patients Across Geographical Regions—A Snapshot From The Dialysis Outcomes and Practice Patterns Study (DOPPS)

Autor Stirnadel-Farrant, Heide A., Karaboyas, Angelo, Cizman, Borut, Bieber, Brian A., Kler, Lata, Jones, Delyth, Cobitz, Alexander R., Robinson, Bruce M.
Vydáno v Kidney Int Rep (2019)

Four-Week Studies of Oral Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia

Autor Holdstock, Louis, Meadowcroft, Amy M., Maier, Rayma, Johnson, Brendan M., Jones, Delyth, Rastogi, Anjay, Zeig, Steven, Lepore, John J., Cobitz, Alexander R.
Vydáno v J Am Soc Nephrol (2016)

Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial

Autor Nangaku, Masaomi, Hamano, Takayuki, Akizawa, Tadao, Tsubakihara, Yoshiharu, Nagai, Reiko, Okuda, Nobuhiko, Kurata, Kyo, Nagakubo, Takashi, Jones, Nigel P., Endo, Yukihiro, Cobitz, Alexander R.
Vydáno v Am J Nephrol (2021)

Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis

Autor Meadowcroft, Amy M, Cizman, Borut, Holdstock, Louis, Biswas, Nandita, Johnson, Brendan M, Jones, Delyth, Nossuli, A Kaldun, Lepore, John J, Aarup, Michael, Cobitz, Alexander R
Vydáno v Clin Kidney J (2018)

Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease

Autor Holdstock, Louis, Cizman, Borut, Meadowcroft, Amy M, Biswas, Nandita, Johnson, Brendan M, Jones, Delyth, Kim, Sung Gyun, Zeig, Steven, Lepore, John J, Cobitz, Alexander R
Vydáno v Clin Kidney J (2018)

Mechanism of action study to evaluate the effect of rosiglitazone on bone in postmenopausal women with type 2 diabetes mellitus: rationale, study design and baseline characteristic...

Autor Fitzpatrick, Lorraine A., Bilezikian, John P., Wooddell, Margaret, Paul, Gitanjali, Kolatkar, Nikheel S., Nino, Antonio J., Miller, Colin G., Bogado, Cesar E., Arnaud, Claude D., Cobitz, Alexander R.
Vydáno v J Drug Assess (2011)